Abbott India share price has plunged 5% and is presently trading at Rs 27,458.2.
Meanwhile, the BSE HEALTHCARE index is at 38,165.5 (down 1.6%).
Among the top losers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (down 6.5%) and LAURUS LABS (down 3.8%).
Jubilant Pharmova (up 1.9%) and ALEMBIC PHARMA (up 0.4%) are among the top gainers today.
Over the last one year, Abbott India has moved up from Rs 23,152.4 to Rs 27,458.2, registering a gain of Rs 4,305.9 (up 18.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,443.1 to 38,165.5, registering a gain of 44.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.1%), Lupin (up 91.4%) and Jubilant Pharmova (up 91.0%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 80,623.2 (down 0.9%).
The top losers among the BSE Sensex today are Tata Steel (down 5.2%) and JSW Steel (down 4.3%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 24,528.8 (down 1.1%). Tata Steel and BPCL are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,589.9 to 80,623.2, registering a gain of 14,033.3 points (up 21.1%).
Abbott India net profit grew 24.0% YoY to Rs 2,871 million for the quarter ended March 2024, compared to a profit of Rs 2,314 million a year ago. Net sales rose 7.1% to Rs 14,386 million during the period as against Rs 13,431 million in January-March 2023.
For the year ended March 2024, Abbott India reported 26.5% increase in net profit to Rs 12,012 million compared to net profit of Rs 9,494 million during FY23. Revenue of the company grew 9.4% to Rs 58,489 million during FY24.
The current Price to earnings ratio of Abbott India, based on rolling 12 month earnings, stands at 48.6.
Equitymaster requests your view! Post a comment on "Abbott India Plunges 5%; BSE HEALTHCARE Index Down 1.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!